Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:37 PM
Ignite Modification Date:
2025-12-24 @ 10:37 PM
NCT ID:
NCT06931535
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years;
* Time from onset to treatment: ≤48 hours;
* Posterior circulation ischemic stroke confirmed by CT or MRI, including patients who have received intravenous thrombolysis or endovascular therapy;
* NIHSS score at randomization: 6-16, with an item 1a (level of consciousness) score of 0-1;
* First-ever stroke or prior stroke without significant residual disability (modified Rankin Scale score ≤1);
* Signed informed consent.
Exclusion Criteria:
* intracerebral hemorrhage or subarachnoid hemorrhage；
* Uncontrolled severe hypertension (systolic blood pressure \>180 mmHg or diastolic blood pressure \>110 mmHg despite antihypertensive therapy)；
* Subclavian artery stenosis ≥ 50% or subclavian steal syndrome;
* Intracranial tumor, arteriovenous malformation or aneurysm;
* Severe abnormalities in coagulation;
* Any contraindication for remote ischemic adaptation: the upper limb has serious soft tissue injury, fracture or vascular injury, distal upper limb perivascular lesions, etc.;
* Participating in other clinical trials within 3 months;
* Comorbidity with any serious diseases and life expectancy is less than half a year;
* Patients not suitable for this clinical studies considered by researcher;
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06931535
Study Brief:
Protocol Section:
NCT06931535